Allworth Financial’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
JT
Allworth Financial's PTCT Position: Q2 2026 in Review
Allworth Financial increased its PTC Therapeutics (PTCT) stake by 21% in Q2 2026, buying an estimated $10.1K and bringing the position to 818 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2240.
Allworth Financial first reported a position in PTCT in Q2 2016 and has held it in 19 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Allworth Financial held 818 shares of PTC Therapeutics worth $66.7K as of Q2 2026.
- Allworth Financial bought 140 PTC Therapeutics shares in Q2 2026, an estimated $10.1K.
- PTC Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2240 holding.
- Allworth Financial first reported a position in PTC Therapeutics in Q2 2016 and has held it in 19 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.